COYA THERAPEUTICS ANNOUNCES U.S. FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR COYA 302 FOR THE TREATMENT OF FRONTOTEMPORAL DEMENTIA (FTD)

Reuters · 5d ago

Please log in to view news